Match the Retina Master: Second-Generation Anti-VEGF Use in nAMD, DME, and RVO
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Vindico Medical Education
Events
Register today for upcoming in-person and virtual events.
From Weight to Integrated Metabolic Health: Strategies for Navigating Obesity, Liver Disease, and Cardiometabolic Risk
This activity is supported by an independent medical educational grant from Boehringer lngelheim Pharmaceuticals, Inc.
10th Annual IBD NOW Summit for Fellows
This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; Johnson & Johnson; Lilly; and Merck & Co., Inc.
Vindico at OSNNY and OSNNY Retina
These activities are held during OSNNY and OSNNY Retina.
Online Activities
Learn and earn credit any time, at your own pace.
The Retina Radar Season 4 With Dr. Arshad Khanani: Clinical Trials at the Summit 2026 With Drs. David Boyer and Anat Loewenstein
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in nAMD Management in 2026 With Dr. Yasha Modi
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in DME Management in 2026 With Dr. Margaret Chang
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
The Retina Radar Season 4 With Dr. Arshad Khanani: What’s New for RVO in 2026? With Dr. Ehsan Rahimy
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
Tools & Resources
View or download to use in your daily practice.
